Company
About us
Acticor Team
Board of Directors
investors & Partners
Prizes & Awards
Our Product
Our product: Glenzocimab
GPVI / GLENZOCIMAB in brief
in acute ischemic stroke
⮑ Positive results actimis study
in other indications
Pipeline
About stroke
Key figures
What is a stroke?
Media
Press Releases
Publications
Media Coverage
Events
Investors
Welcome
Corporate Presentation
Share Overview
Shareholders' Meeting
Regulated Information
Financial Agenda
COntact
Investors
Other Regulated Information
pp
2023
2022
2021
PDF
August 2023
Number of shares and voting rights – August 2023
PDF
July 2023
Number of shares and voting rights – July 2023
PDF
June 2023
Half year report for liquidity contract – June 30, 2023
PDF
June 2023
Number of shares and voting rights – June 2023
PDF
May 2023
Number of shares and voting rights – May 2023
PDF
April 2023
Number of shares and voting rights – April 2023
PDF
March 2023
Number of shares and voting rights – March 2023
PDF
February 2023
Number of shares and voting rights – February 2023
PDF
January 2023
Number of shares and voting rights – January 2023
→ Welcome
→ Share Overview
→ Corporate Presentation
→ Shareholders' Meeting
→ Regulated Information
→ Financial Information
→ Other Regulated Information
→ Governance
→ Financial Agenda
→ Contact
Ask Us Your Questions
Subscribe To Email Alert
